GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jolt Health Inc (XCNQ:JOLT) » Definitions » EPS (Diluted)

Jolt Health (XCNQ:JOLT) EPS (Diluted) : C$-0.01 (TTM As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Jolt Health EPS (Diluted)?

Jolt Health's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was C$-0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.01.

Jolt Health's EPS (Basic) for the three months ended in Mar. 2024 was C$-0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.01.

Jolt Health's EPS without NRI for the three months ended in Mar. 2024 was C$-0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.01.

During the past 3 years, the average EPS without NRIGrowth Rate was 29.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 9.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Jolt Health's highest 3-Year average EPS without NRI Growth Rate was 67.00% per year. The lowest was -176.60% per year. And the median was 16.55% per year.


Jolt Health EPS (Diluted) Historical Data

The historical data trend for Jolt Health's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jolt Health EPS (Diluted) Chart

Jolt Health Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.05 -0.01 -0.44 -0.09 -0.01

Jolt Health Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 - - - -

Competitive Comparison of Jolt Health's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Jolt Health's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jolt Health's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jolt Health's PE Ratio distribution charts can be found below:

* The bar in red indicates where Jolt Health's PE Ratio falls into.



Jolt Health EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Jolt Health's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.766-0)/65.167
=-0.01

Jolt Health's Diluted EPS for the quarter that ended in Mar. 2024 is calculated as

Diluted EPS (Q: Mar. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.212-0)/79.487
=-0.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jolt Health  (XCNQ:JOLT) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Jolt Health EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Jolt Health's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Jolt Health (XCNQ:JOLT) Business Description

Traded in Other Exchanges
Address
355 Burrard Street, Suite 1780, Marine Building, Vancouver, BC, CAN, V6C 2G8
Jolt Health Inc, formerly Love Pharma Inc is a licensee of certain technologies relating to certain controlled substances and pharmaceutical-grade therapeutics. The company is investigating business opportunities in other industries however has not reached a definitive decision to pursue alternative lines of business.

Jolt Health (XCNQ:JOLT) Headlines

No Headlines